New Research Discovers that Kerry Group’s Wellmune Offers Unique Way to Support Everyday Immune Health
Kerry Group announced that Wellmune, a postbiotic ingredient supported by over a dozen clinical studies documenting its ability to support the immune system, has been confirmed in a study as a trainer of the innate immune system (one of two major immune system functions). A proprietary baker’s yeast beta 1,3/1,6 glucan postbiotic, Wellmune works by training innate immune cells at key sites around the body to be ready for action, helping them to find foreign invaders that may harm health.
Recent consumer research underscores the importance of science-backed efficacy, revealing that “clinically proven” is the #1 claim that consumers want to see on food, beverage and supplement products targeting immune health. Wellmune is unique in that it is the first ingredient targeting immune health with clinically studied capability to train the immune system via oral consumption.
With a shift in consumer behavior towards a more proactive approach to health management, the concept of training the immune system is gaining recognition as a powerful mechanism for consumers looking for novel, science-backed ways to support their immune health. A newly published iScience research article titled, “Recognition of yeast β-glucan particles triggers immunometabolic signaling required for trained immunity” addresses this demand by unveiling a new way to support immune health through intentionally training the immune system with Wellmune. The research shows that Wellmune works on the inflammatory and antimicrobial behavior of monocytes and macrophages, cells that are a critical part of the innate immune system. When Wellmune is taken orally, it trains immune cells, creating an environment in which they efficiently respond to unpredictable health threats without delay.
Wellmune accomplishes this by training innate immune cells to use and store energy more efficiently, so they can effectively safeguard the body and combat potential threats. Wellmune has been extensively studied for the past 15 years, with clinical research consistently demonstrating its preparation, priming, and training of innate immune cells to provide support for both adults and children facing health challenges. In an unpredictable world where health challenges can arise at any time, a trained immune system is essential in providing support for daily health.
Compared to other yeast beta glucans on the market, Wellmune offers a unique source, structure and mechanism of action. It’s a safe and versatile postbiotic for everyday consumption in a wide variety of functional foods and beverages, dietary supplements and pet products where immune health is intended as a key benefit. Wellmune has regulatory approval in major markets around the world, including Generally Recognized as Safe (GRAS) status by the FDA in the United States and Novel Food Approval in Europe and China. Immune health products containing Wellmune are available in more than 60 countries.
“The surge in the market for immune health products over the past decade has been remarkable, and Wellmune’s clinically proven capacity to train the immune system stands as a true beacon of innovation for the industry,” said Jordan Dow, Vice President, Kerry ProActive Health. “Wellmune is a one-of-a-kind solution proactively tackling the pressing health and wellness concerns of our customers. With its studied capabilities for immunity defense, we’re providing a solution that not only fosters overall health and wellbeing, but also sets a premium standard in the industry.”